1.2 billion rubles will be invested by the resident of the special economic zone Dubna in the production of vacuum tubes

7 June 2019
On June 6, during the St. Petersburg International Economic Forum (SPIEF), the Deputy Prime Minister of the Moscow region Vadim Khromov and the General Director of Granat Bio Tech LLC Alexander Shishov signed a cooperation agreement, according to which a research and production complex and production systems will be built in Special Economic Zone Dubna for the collection, storage and transportation of biomaterials.

As Vadim Khromov said, the investment in the project will amount to 1.2 billion rubles, 140 new jobs will be created with an average salary of 50 thousand rubles.

- At the moment, the company has already completed construction of the first stage with an area of more than 6 thousand square meters - added deputy chairman. - To implement the project, a land plot was leased on the territory of the Dubna SEZ with an area of 2.81 hectares. It is planned to complete the project in the third quarter of 2022. Also, after the facility is commissioned, the company plans to take part in a tender to reimburse the costs of creating engineering infrastructure.

Granat Bio Tekh LLC is a medical research and production complex for the production of modern disposable medical products from plastic for laboratory diagnostics. The company was established in 2016 and since August of the same year has been a resident of the Dubna special economic zone.

“The Government of the Moscow region is doing a very important job in terms of creating an attractive investment environment and developing enterprises in the region,” said Alexander Shishov, General Director of Granat Bio Tech LLC. - In modern economic conditions, this is the right step, which we, the representatives of production, appreciate and support. In turn, this allows us to introduce the latest advanced technologies and provide the region with high-tech workplaces, as well as produce a modern product that meets all the requirements of world leaders for domestic clinical diagnostic laboratories.

At the end of May, the Expert Council of the Industry Development Fund approved the company Granat Bio Tech a loan of 389 million rubles for the creation of a serial production of medical bilateral needles for taking venous blood. Its capacity will be 80 million units per year. As a result of the project implementation by the resident in special economic zone Dubna, the share of foreign companies in the Russian market may decrease from 100 to 70%.

All news